Literature DB >> 29534630

Antibiotic Use in the Intensive Care Unit: Optimization and De-Escalation.

Maureen Campion1, Gail Scully1.   

Abstract

Appropriate antimicrobial therapy is essential to ensuring positive patient outcomes. Inappropriate or suboptimal utilization of antibiotics can lead to increased length of stay, multidrug-resistant infections, and mortality. Critically ill intensive care patients, particularly those with severe sepsis and septic shock, are at risk of antibiotic failure and secondary infections associated with incorrect antibiotic use. Through the initiation of active empiric antibiotic therapy based upon local susceptibilities, daily evaluation of signs and symptoms of infection and narrowing of antibiotic therapy when feasible, providers can streamline the treatment of common intensive care unit (ICU) infections. Optimizing antibiotic dosing through prolonged infusions can be beneficial in intensive care populations with altered pharmacokinetics. Antimicrobial stewardship teams can assist ICU providers in managing and implementing these tactics. This review will discuss the current literature on antibiotic use in the ICU applying antimicrobial stewardship strategies. Based upon the most recent evidence, ICUs would benefit from employing empiric guidelines for antibiotic use, collecting appropriate specimens and implementing molecular diagnostics, optimizing the dosing of antibiotics, and reducing the duration of total therapy. These strategies for antibiotic use have the potential to enhance patient care while preventing adverse outcomes.

Entities:  

Keywords:  antibiotic utilization; antibiotics; antimicrobial stewardship; critically ill patients; infection; intensive care

Mesh:

Substances:

Year:  2018        PMID: 29534630     DOI: 10.1177/0885066618762747

Source DB:  PubMed          Journal:  J Intensive Care Med        ISSN: 0885-0666            Impact factor:   3.510


  25 in total

1.  Antimicrobial Stewardship in Hematological Patients at the intensive care unit: a global cross-sectional survey from the Nine-i Investigators Network.

Authors:  Jordi Rello; Cristina Sarda; Djamel Mokart; Kostoula Arvaniti; Murat Akova; Alexis Tabah; Elie Azoulay
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2019-11-09       Impact factor: 3.267

2.  Current clinical use of intravenous fosfomycin in ICU patients in two European countries.

Authors:  C Putensen; B Ellger; S G Sakka; A Weyland; K Schmidt; M Zoller; N Weiler; D Kindgen-Milles; U Jaschinski; J Weile; S Lindau; M Kieninger; A Faltlhauser; N Jung; P Teschendorf; M Adamzik; M Gründling; T Wahlers; H Gerlach; F-A Litty
Journal:  Infection       Date:  2019-06-12       Impact factor: 3.553

3.  Preparedness of pharmacists to respond to the emergency of the COVID-19 pandemic in Brazil: a comprehensive overview.

Authors:  Maria Auxiliadora Parreiras Martins; Amanda Fonseca de Medeiros; Claudmeire Dias Carneiro de Almeida; Adriano Max Moreira Reis
Journal:  Drugs Ther Perspect       Date:  2020-07-31

4.  Rapid identification and antimicrobial susceptibility testing of Gram-negative rod on positive blood cultures using MicroScan panels.

Authors:  A Infante; V Ortiz de la Tabla; C Martín; G Gázquez; F Buñuel
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2020-08-29       Impact factor: 3.267

5.  Antibiotic therapy-induced collateral damage: IgA takes center stage in pulmonary host defense.

Authors:  Juergen Lohmeyer; Rory E Morty; Susanne Herold
Journal:  J Clin Invest       Date:  2018-07-16       Impact factor: 14.808

6.  Predictive modeling of bacterial infections and antibiotic therapy needs in critically ill adults.

Authors:  Garrett Eickelberg; L Nelson Sanchez-Pinto; Yuan Luo
Journal:  J Biomed Inform       Date:  2020-08-16       Impact factor: 6.317

7.  Physician Responsiveness to Positive Blood Culture Results at the Minneapolis Veterans Affairs Hospital-Is Anyone Paying Attention?

Authors:  Shaun Heimbichner Johnson; Steven James Waisbren
Journal:  Fed Pract       Date:  2021-03

8.  Effective implementation of the Accelerate Pheno™ system for positive blood cultures.

Authors:  Romney Humphries; Tiziana Di Martino
Journal:  J Antimicrob Chemother       Date:  2019-01-01       Impact factor: 5.790

9.  Moderate positive predictive value of a multiplex real-time PCR on whole blood for pathogen detection in critically ill patients with sepsis.

Authors:  Kirsten van de Groep; Martine P Bos; Meri R J Varkila; Paul H M Savelkoul; David S Y Ong; Lennie P G Derde; Nicole P Juffermans; Tom van der Poll; Marc J M Bonten; Olaf L Cremer
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2019-06-26       Impact factor: 3.267

10.  A Comparison of Blood Pathogen Detection Among Droplet Digital PCR, Metagenomic Next-Generation Sequencing, and Blood Culture in Critically Ill Patients With Suspected Bloodstream Infections.

Authors:  Bangchuan Hu; Yue Tao; Ziqiang Shao; Yang Zheng; Run Zhang; Xuejing Yang; Jingquan Liu; Xi Li; Renhua Sun
Journal:  Front Microbiol       Date:  2021-05-17       Impact factor: 5.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.